Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United Health Products (UEEC) EBT (2016 - 2025)

United Health Products (UEEC) has disclosed EBT for 15 consecutive years, with -$263863.0 as the latest value for Q3 2025.

  • On a quarterly basis, EBT rose 33.95% to -$263863.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.8 million, a 68.33% decrease, with the full-year FY2024 number at -$2.0 million, up 17.54% from a year prior.
  • EBT was -$263863.0 for Q3 2025 at United Health Products, up from -$268356.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of -$263863.0 in Q3 2025 to a low of -$27.1 million in Q1 2021.
  • A 5-year average of -$2.1 million and a median of -$562110.0 in 2022 define the central range for EBT.
  • Peak YoY movement for EBT: plummeted 4243.5% in 2021, then soared 96.48% in 2022.
  • United Health Products' EBT stood at -$907300.0 in 2021, then surged by 38.05% to -$562110.0 in 2022, then rose by 24.85% to -$422409.0 in 2023, then crashed by 85.93% to -$785398.0 in 2024, then skyrocketed by 66.4% to -$263863.0 in 2025.
  • Per Business Quant, the three most recent readings for UEEC's EBT are -$263863.0 (Q3 2025), -$268356.0 (Q2 2025), and -$1.5 million (Q1 2025).